1. Home
  2. EXTR vs MIRM Comparison

EXTR vs MIRM Comparison

Compare EXTR & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXTR
  • MIRM
  • Stock Information
  • Founded
  • EXTR 1996
  • MIRM 2018
  • Country
  • EXTR United States
  • MIRM United States
  • Employees
  • EXTR N/A
  • MIRM N/A
  • Industry
  • EXTR Telecommunications Equipment
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • EXTR Telecommunications
  • MIRM Health Care
  • Exchange
  • EXTR Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • EXTR 2.4B
  • MIRM 2.0B
  • IPO Year
  • EXTR 1999
  • MIRM 2019
  • Fundamental
  • Price
  • EXTR $16.61
  • MIRM $42.04
  • Analyst Decision
  • EXTR Strong Buy
  • MIRM Strong Buy
  • Analyst Count
  • EXTR 5
  • MIRM 11
  • Target Price
  • EXTR $19.00
  • MIRM $57.00
  • AVG Volume (30 Days)
  • EXTR 804.1K
  • MIRM 376.0K
  • Earning Date
  • EXTR 01-29-2025
  • MIRM 02-26-2025
  • Dividend Yield
  • EXTR N/A
  • MIRM N/A
  • EPS Growth
  • EXTR N/A
  • MIRM N/A
  • EPS
  • EXTR N/A
  • MIRM N/A
  • Revenue
  • EXTR $1,033,270,000.00
  • MIRM $307,028,000.00
  • Revenue This Year
  • EXTR $2.76
  • MIRM $82.14
  • Revenue Next Year
  • EXTR $8.36
  • MIRM $26.18
  • P/E Ratio
  • EXTR N/A
  • MIRM N/A
  • Revenue Growth
  • EXTR N/A
  • MIRM 112.14
  • 52 Week Low
  • EXTR $10.50
  • MIRM $23.14
  • 52 Week High
  • EXTR $19.24
  • MIRM $48.89
  • Technical
  • Relative Strength Index (RSI)
  • EXTR 42.38
  • MIRM 47.79
  • Support Level
  • EXTR $17.48
  • MIRM $40.91
  • Resistance Level
  • EXTR $18.09
  • MIRM $42.40
  • Average True Range (ATR)
  • EXTR 0.58
  • MIRM 1.45
  • MACD
  • EXTR -0.22
  • MIRM -0.13
  • Stochastic Oscillator
  • EXTR 7.39
  • MIRM 51.04

About EXTR Extreme Networks Inc.

Extreme Networks Inc provides cloud networking solutions and industry services and support. Extreme designs, develops, and manufactures wired, wireless, and software-defined wide area-network (SD- WAN) infrastructure equipment, software and cloud-based network management solutions. The company's cloud solution is a single platform that offers unified network management of wireless access points, switches, and SD-WAN. The company operates in a single segment which develops and markets network infrastructure equipment. Roughly half of the firm's revenue is generated in the Americas, with the rest coming from Europe, the Middle East, Africa, and Asia-Pacific.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter "IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: